Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 5/20 | 0.62 |
| ▸ | MAOB | P27338 | 2/20 | 0.61 |
| ▸ | HTR7 | P34969 | 1/20 | 0.60 |
| ▸ | HRH1 | P35367 | 1/20 | 0.60 |
| ▸ | DRD3 | P35462 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28713961 | 0.91 | HTR1A (0.65) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL28701584 | 0.91 | HTR1A (0.65) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL28701586 | 0.91 | HTR1A (0.65) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL29459473 | 0.91 | HTR1A (0.65) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL29459577 | 0.91 | HTR1A (0.65) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL13469510 | 0.87 | HTR1A (0.79) | HTR1AMAOBDRD3DRD2 | |
| SCHEMBL5113354 | 0.86 | HTR1A (0.61) | HTR1AMAOBHTR7HRH1DRD3 | |
| SCHEMBL7989673 | 0.84 | HTR1A (0.62) | HTR1AMAOBHTR7DRD3ALDH1A1 | |
| SCHEMBL1569172 | 0.83 | HTR1A (0.69) | HTR1AMAOBDRD3DRD2 | |
| SCHEMBL14028451 | 0.83 | HTR1A (0.79) | HTR1AMAOBDRD3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547672-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-119233976-A | Modulators of c-MYC mRNA translation and their use in the treatment of cancer | 艾尼莫生物科技公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-114174303-B | Macrocyclic compounds as STING agonists and methods and uses thereof | 印度鲁宾有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024010762-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| EP-4004002-A1 | MACROCYCLIC COMPOUNDS AS STING AGONISTS AND METHODS AND USES THEREOF | Lupin Limited (IN) | 2022-06-01 | — | — | EP | disclosed |
| CN-114174303-A | Macrocyclic compounds as STING agonists, methods and uses thereof | 印度鲁宾有限公司 | 2022-03-11 | — | — | CN | disclosed |